A study of 11 cases of B cell precursor (BCP) acute lymphoblastic leukemia found that the combination of PTL and the BCL-2 inhibitor ABT-263 significantly reduced cell viability. The gene discussed is PNLIP; the disease is acute lymphoblastic leukemia.